(Q35593781)

9 August 2017

1 reference

title

Non-pharmacological interventions in cognitively impaired and demented patients--a comparison with cholinesterase inhibitors (English)

1 reference

non-pharmaceutical intervention

9 August 2017

1 reference

4

Dick F Swaab

1 reference

9 August 2017

2

Erik J A Scherder

1 reference

9 August 2017

5

Joseph A Sergeant

1 reference

9 August 2017

Marijn W Luijpen

1

1 reference

PubMed ID

14640320

9 August 2017

Eus J W Van Someren

series ordinal

3

1 reference

9 August 2017

1 January 2003

1 reference

Reviews in the Neurosciences

9 August 2017

1 reference

9 August 2017

14

1 reference

9 August 2017

4

1 reference

9 August 2017

343-368

1 reference

Effect of light treatment on sleep and circadian rhythms in demented nursing home patients

9 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Dementia with lewy bodies: findings from an international multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

The effects of light therapy on mini-mental state examination scores in demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Evaluation of a mental test score for assessment of mental impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Using multi-sensory environments with older people with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

The effect of expressive physical touch on patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Synaptic plasticity in cortical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Sensory responsiveness of "broad-spike" neurons in the laterodorsal tegmental nucleus, locus coeruleus and dorsal raphe of awake rats: implications for cholinergic and monoaminergic neuron-specific responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Ageing, fitness and neurocognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Psychobiology of plasticity: effects of training and experience on brain and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Diminished neuronal metabolic activity in Alzheimer's disease. Review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Publication Decisions and Their Possible Effects on Inferences Drawn from Tests of Significance--Or Vice Versa

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Brain aging and Alzheimer's disease, “Wear and tear” versus “Use it or lose it”

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

A study of subcortical afferents to the hippocampal formation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

Tacrine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

A Standardized Memory Scale for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

The cognitive drug research computerized assessment system for demented patients: A validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2003.14.4.343

10.1515/REVNEURO.2003.14.4.343

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14640320